-
ACHL Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
-
Insider
- Institutional
- Shorts
Achilles Therapeutics (ACHL)
Company Profile
Quarter (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 18 |
Opened positions | 4 |
Closed positions | 3 |
Increased positions | 1 |
Reduced positions | 5 |
13F shares | Current |
---|---|
Total value | 16.13 bn |
Total shares | 22.04 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Syncona Portfolio | 11.09 mm | $10.48 bn |
Baker Bros. Advisors | 2.56 mm | $2.42 bn |
Artal | 2.26 mm | $2.13 mm |
Artal International S.C.A. | 2.26 mm | $0.00 |
Redmile | 1.61 mm | $1.52 bn |
Point72 Asset Management | 1.41 mm | $1.34 bn |
Renaissance Technologies | 449.73 k | $425.00 k |
EDENTREE ASSET MANAGEMENT | 100.00 k | $94.52 mm |
Forefront Analytics | 74.77 k | $70.67 mm |
MS Morgan Stanley | 72.75 k | $68.77 mm |